IE49358B1 - Carbamate derivatives of hydroxy prolines - Google Patents

Carbamate derivatives of hydroxy prolines

Info

Publication number
IE49358B1
IE49358B1 IE498580A IE498580A IE49358B1 IE 49358 B1 IE49358 B1 IE 49358B1 IE 498580 A IE498580 A IE 498580A IE 498580 A IE498580 A IE 498580A IE 49358 B1 IE49358 B1 IE 49358B1
Authority
IE
Ireland
Prior art keywords
proline
methyl
trans
acetylthio
carbonyljoxyj
Prior art date
Application number
IE498580A
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IE49358B1 publication Critical patent/IE49358B1/en

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

This invention provides carbamate derivatives of hydroxy prolines which are intermediates used in the preparation of carbamate derivatives of mercaptoacyl hydroxy prolines which have the formula R,_s _(ch)-ch_co » n » (I) wherein each of R, R2 and R^, which are similar or dissimilar, is hydrogen, lower alkyl, or trifluoromethyl; each of RQ and R^, which are similar or dissimilar, is hydrogen, lower alkyl, lower cycloalkyl, allyl, propargyl, phenyl or substituted phenyl;’ or Rq and R^ can, together with the nitrogen atom to which they are both attached form a 5- or 6membered heterocyclic ring preferably pyrrolidine, piperidine or morpholine; R^ is hydrogen or a hydrolyzable organic protecting group of the formula Rg—CO—or Rg is lower alkyl, phenyl, substituted phenyl, phenyllower alkyl, substituted phenyl-lower alkyl, cycloalkyl, thienyl or furyl; n is 0, 1 or 2; and salts thereof; (see our co-pending Irish Patent Application No. 48/80).
In the formula, the substituents on any phenyl groups is preferably halogen,lower alkyl, lower alkoxy, lower alkylthio or trifluoromethyl.
The asterisks indicate centers of asymmetry. The carbon in the acyclic side chain is asymmetric when R2 and/or R^ is other than hydrogen. Each of the centers of asymmetry provide D and L forms which can be separated by conventional methods as described below. The carbamate group —OCON R, also gives rise to cis-trans isomerism.
The present invention provides compounds of the formula HN COOH OCO-N ./Ko wherein RQ and R^ have'the meanings given above.
The lower alkyl groups represented by any of the variables are straight and branched chain hydrocarbon radicals having up to seven carbons, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, and isopentyl. The lower alkyl groups having - 3 49358 up to four carbons and especially the and C2 members are preferred.
The cyclo-lower alkyl groups are the alicyclic groups having up to seven carbons, i.e., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl.
Cyclopentyl and cyclohexyl are preferred.
The substituted phenyl groups include monosubstituted phenyl rings wherein the phenyl substituent is halogen, lower alkyl, lower alkoxy, lower alkylthio or frifluoromethyl, the lower alkoxy and lower alkylmercapto groups include lower alkyl groups of the type described above. Exemplary are methoxy, ethoxy, propoxy isopropoxy, butoxy, t-butoxy, methylthio, ethylthio, propylthio, isopropylthio and like. The C^—C^ and preferences described above also apply. The halogens are the four common halogens, preferably chlorine and bromine, providing such radicals as 0-, m- and p- chlorophenyl, 0-, m- and p-promophenyl and the like. The phenyl and substituted phenyl can also be described as wherein Rg is hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio or trifluoromethyl.
The phenyl-lower alkyl groups include lower alkyl groups of the type described above attached to the phenyl ring. Phenylmethyl and phenylethyl are the preferred phenyl-lower alkyl groups, especially phenylmethyl.
The preferred groups of the formula Rg—CO— are those wherein Rg is lower alkyl, phenyl, or phenyllower alkyl.
The lower alkanoyl groups represented by Rg—CO— are those having the acyl radicals of the lower (Cj—C?) fatty acids, for example, acetyl, propionyl, butyryl, isobutyryl and the like. Those lower alkanoyl groups having up to four carbons, and especially acetyl, are preferred. The same preferences apply to the phenyl-lower alkanoyl groups where Rg in the group Rg—CO— is phenyllower alkyl, Benzoyl is especially preferred.
The carbamate group on the pyrrolidine ring can be acylic including, for example, the radicals carbamoyl, lower alkylcarbamoyl such as methylcarbamoyl, ethylcarbamoyl, propylcarbamoyl, isopropylcarbamoyl, di(lower alkyl)carbamoyl such as dimethylcarbamoyl, diethylcarbamoyl, propargyl carbamoyl, or allylcarbamoyl.
It also includes cycloalkylcarbamoyl groups such as cyclopentylcarbamoyl, dicyclopentylcarbamoyl, cyclohexylcarbamoyl, dicyclohexylcarbamoyl and the like.
In addition it includes phenyl- and substituted phenyl carbamoyl groups such as phenylcarbamoyl, 4-chiorophenylcarbamoyl, 3-ethylphenylcarbamoyl, 4-methoxyphenylcarbamoyl, 4- (trifluoromethyl)phenylcarbamoyl and the like. Preferably only one of Rq and R^ is a cycloalkyl, phenyl or substituted phenyl radical.
The R, can also form a 5-membered or 6-membered heterocyclic of the group pyrrolidine, piperidine or morpholine.
Preferably only one of Rq and R^ is other than hydrogen except when both Rq and R^ are lower alkyl.
Preferred compounds of formula 1 are those wherein R is hydrogen or lower alkyl; RQ and R^ each is independently —C^-lower alkyl, R2 and R^ each is hydrogen or —C4~lower alkyl; R^ is hydrogen, lower alkanoyl, or benzoyl; and n is 0 or 1. The carbamate group is in the 3- or 4-position of the pyrrolidine ring, preferably the 4-position.
Especially preferred are compounds of formula 1 wherein R is hydrogen; Rq and each is lower alkyl, most especially —C^-lower alkyl; R2 is methyl; R3 is hydrogen; R^ is hydrogen; n is 1; and the carbamate group is in the 4-position.
The preferred method of synthesizing compounds of formula 1 utilizes as starting material a hydroxyproline of the formula rf HN-L- COOH (II) The nitrogen is first protected, e.g., with a nitrogen protecting group of the type commonly used in peptide synthesis such as carbobenzoxy, p-toluenesulfonyl, acetyl or the like to obtain a protected compound such as A Cbz-N_I OH .COOH (HI) wherein Cbz is the carbobenzyoxy protecting group.
The protected compound III is then esterified, for example, by reaction with a diazoalkane, such as diazomethane to form an ester of the structure Cbz n° -N-*— (IV) ’ COOR wherein R is lower alkyl like methyl or isobutyl, preferably methyl.
The carbamate group - 7 49358 organic solvent such as benzene, the next intermediate having the In the preparation of the Ro / —OCO—N \ R, wherein RQ is hydrogen and R^ is other than hydrogen, can then be introduced by reacting the compound of formula IV with an isocyanate (R^—NCO) in an inert and the like to obtain formula (V) cis isomer, the above reaction is carried out in the presence of a catalytic 10 amount of a base, such as pyridine or triethylamine.
Alternatively, compounds of formula V may be prepared by reacting the protected compound IV with phosgene to form an intermediate of formula VI /x^OCOCl Cbz-N-1— COOR (which is not necessarily Isolated) with the appropriate amine (VI) which is then reacted \ R, - 49358 or ΝΗ^(where both RQ and are to be hydrogen) to form the formula V compound.
When Rq and R^dn formula V) are both to be other than hydrogen or together complete a heterocyclic, then the protected compound of formula XV is made to react with the carbamoyl halide / hat—CO—N \ Ro Ri (VII) wherein hal is halogen, preferably chlorine.
Alkaline hydrolysis of the compound of formula V with a base such as sodium hydroxide, barium hydroxide, potassium hydroxide or the like yields the acid having the formula xR° OCON rl Cbz-N 1 -— COOH (VIII) The compound of formula VIII in acid or ester form can then be deprotected, e.g., by the conventional procedure of hydrogenation in the presence of palladiumcarbon to obtain the compound of the invention having the formula OCO-N XRo B (IX) UN-l—COOH - 9 49358 The next stage of the synthesis entails coupling the proline derivative IX with an acid having the formula R3 r2 R5—CO—S—(CH)„—CH—COOH (X) most conveniently in the form of an acid chloride, yielding a product of the formula R,— CO-S- (CH) I2 -CH -co-d OCO-N.
X, (XI) COOH The proline derivative XI is preferably isolated and purified by crystallization, e.g., by forming a salt such as the dicyclohexylamine salt and then converting the salt to the free acid form by treatment with an aqueous solution of an acid, such as potassium acid sulfate.
The product of formula XI bearing the acyl group R5—CO can be converted, if desired, to the product of formula 1 wherein R^ is hydrogen by hydrolysis with ammonia, sodium hydroxide or the like.
Esters of formula 1 wherein R is lower alkyl can be obtained by conventional esterification procedures e.g., by esterification with a diazoalkane such as diazomethane, l-alkyl-3-p-toIyltriazene, 1-n-butyl3-p-tolyltriazene, or the like, preferably after the completion of the sequence of reactions described above. However, earlier esterification and omission of the alkaline hydrolysis can also be practices.
The compounds of formula 1 wherein forms the symmetrical bis compound are obtained by directly oxidizing with iodine a product of formula 1 wherein R^ is hydrogen.
Reference is also made to the following publications of additional illustrative information with respect to the production of starting materials and intermediates: U.S. Patents 4,046,889 and 4,105,776; J. Chem. Soc., 1945, 429—432; J. Amer. Chem. Soo. 79, 185—192 (1957); J.Amer. Soc.85, 3863—3865 (1963). The procedures illustrated therein can be utilized as general methods for the synthesis and stereooonversion of compounds utilizable in the invention of this application.
Additional experimental details are found in the examples which are preferred embodiments and also serve as models for the preparation of other compounds.
As indicated above, the compounds of this invention have centers of asymmetry. These compounds accordingly exist in stereoisomeric forms or in racemic mixtures thereof. The various stereoisomeric forms and mixtures thereof are all within the scope of this invention. The above described methods of synthesis can utilize the racemate or one of the enantiomers as starting material. When a mixture of stereoisomers is obtained as the product, the stereoisomeric forms can be separated, if desired, by conventional chromatographic or fractional crystallization methods or by conversion to a salt with an optically active base, followed by fractional crystallization or similar known methods. In general, those compounds are preferred wherein the proline moiety is in the L-configuration and the carbamate group is cis.
The following examples are illustrative of the invention and constitute preferred embodiments; they illustrate compounds of the invention and their use in preparing compounds of formula (1). They also serve as models for the preparation of other compounds which can be produced by replacement of the given reactants with suitably substituted analogs. All temperatures are in degrees Celsius.
EXAMPLE 1 trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4- CC (methylamino)carbonyljoxyJ-L-proline ’ 493B8 a) H-carbobenzyloxy-trans-4-hydroxy-L-proline 26.5 g (0.20 mole) of trans-4-hydroxy-L-proline and 32.8ml (0.23 mole) of benzyl chloroformate are reacted in 200 ml of water and 100 ml of acetone in the presence of 20 g (0.20 mole) of potassium bicarbonate and 69.2 g (0.50 mole) of potassium carbonate and worked up with 90 ml of concentrated hydrochloric acid as described in Can.J. Biochem & Physiol. 37, 584 (1959).
The product is reacted with cyclohexylamine to form the cyclohexylamine salt, yield 69 g, m.p. 193—195°. The salt (34 g) is neturalized with N hydrochloric acid to obtain 27 g of the free acid as a colorless glass -70° (c, 1% in chloroform). b) N-carbobenzyloxy-trans-4-hydroxy-L-proline, Methyl Ester 12.4 g (0.047 mole) of N-carbobenzyloxy-trans-4hydroxy-L-proline is esterified with diaxomethane in dioxane-ether as described in J.A.C.S. 79 191 (1957).
To avoid freezing of the dioxane the addition of the diazomethane is begun at 10° and completed at 0—2°.
The yield of N-carbobenzyloxy-trans-4-hydroxy-L-proline, methyl ester as a nearly colorless viscous oil is 14.6 g (100%). Ea326 - 62° (c, 1% in chloroform). c) trans-N-carbobenzyloxy-4-CC(methylamino)carbonyl3oxv3Lproline, Methyl Ester To a stirred solution of 6.0 g (0.021 mole) of - 13 49358 N-carbobenzyloxy-trans-4-hydroxy-L-proline, methyl ester (J.A.C.S. 79 supra) in 120 ml of benzene is added 6 ml (O.lOmole) of methylisocyanate and the reaction mixture kept overnight at room temperature. After refluxing for one hour, the solvent is removed on a rotary evaporator, finally at 0.2 mm and 50°. The viscous residue is taken up in 150 ml of ether, washed with water (3X50 ml), dried (MgSO4), and the ether is evaporated to yield 6.5 g (90%) of syrupy product, trans-Ncarbobenzyloxy-4-CE(methylamino)carbonylJoxyJ-L-proline, methyl ester. d) trans-M-carbobenzyloxy-4-CE(methylamino)carbonyljoxyjL-proline The crude ester from part c (7.6 g, 0.023 mole) is dissolved in 60 ml of methanol, treated dropwise at —1° to 4° with 14 ml (0.028 mole) of 2N sodium hydroxide, kept at 0° for one hour, and at room temperature overnight. After removing about 1/2 of the solvent on a rotary evaporator, the solution is diluted with 160 ml of water, washed with ether (wash discarded), acidified, while cooling, with 5.5 ml of 1:1 hydrochloric acid, to pH 2, and extracted with ethyl acetate (4X75ml). The combined extracts are washed with 50 ml of saturated sodium chloride, dried (MgSO^) and the solvent evaporated to give 7.2 g of a very viscous syrup. The syrup is dissolved in 30 ml of ethanol, treated with 2.3 g of cyclohexylamine in 5 ml of ethanol and diluted to 600 ml with ether. On seeding and rubbing, the crystalline cyclohexylamine salt separates; weight after cooling overnight, 8.5 g; m.p. 172—174°. EaZ)33 - 20° (c, 1% in ethanol). Following crystallization from 25 ml of isopropanol, the colorless solid trans-Ncarbobenzyloxy-4-CC(methylamino)carbonyl]oxy]-L-propline cyclohexylamine salt weighs 7.8 g, m.p. 174—176°. Εούθ518° (c, 1% in ethanol).
The cyclohexylamine salt is suspended in 60 ml of ethyl acetate, stirred, and treated with 40 ml of N hydrochloric acid. When two clear layers are obtained they are separated, the aqueous phase is extracted with additional ethyl acetate (3X60 ml), the combined organic layers are dried (MgSO4), and the solvent evaporated.
The yield of glass-like free acid is 5.5 g (81%). e) trans-4-CC(methylamino)carbonyl]oxyZ|-L-proline A solution of 2.7 g (0.0084 mole) of trans-Ncarbobenzyloxy3-4~EC(methylamino)carbonyl]oxy3-Lproline in 100 ml of methanol-water (2:1) is treated with lg of 5% palladium-carbon and 45 lb of hydrogen and shaken on a Parr hydrogenator for 6 hours. The catalyst is filtered off under nitrogen, washed with methanol and the combined filtrates are evaporated, finally at 0.1—0.2 mm, to give 1.5 g (96%) of a residue which gradually crystallizes to give trans -4-(l(methylamino)carbonylDoxyj-L-proline as a greyish solid; m.p. 213—215° (dec), preceded by gradual darkening and sintering. Ea3^®-12°(c, 0.25% in 1:3 ethanol-methanol). f) trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropylD-Lproline A stirred solution of 2.9 g (0.0154 mole) of trans-4-EE(methylamino)carbonylJoxyJ-L-proline in 45 ml of water is cooled to 5° and treated portionwise with solid sodium carbonate to pH 8.5; (approx. 0.4 g required).
Then while continuing stirring and cooling, a solution of 3.1 g (0.017 mole) of D-3-acetylthio-2-methylpropanoyl chloride in 4 ml of ether is added portionwise by means of a pipette while maintaining the pH at 7.0—8.0 by dropwise addition of 25% (w/v) sodium carbonate. After about 10 minutes, the pH stabilizes at 8.1—8.3 (about 14 ml of the sodium carbonate solution has been added). After continued stirring and cooling for a total of 1.25 hours, the solution is washed with ethyl acetate (50 ml), layered over with 50 ml of ethyl acetate, stirred, cooled, acidified carefully with 1:1 hydrochloric acid to pH 2.0, saturated with sodium chloride and the layers are separated.
The aqueous phase is extracted with additional ethyl acetate ‘ 49358 (3X50 ml), the combined organic layers are dried (MgSO^) and the solvent evaporated, finally at 0.2 mm, to give 5.3 g of a glass-like residue. The latter is dissolved in 40 ml of ethyl acetate and treated with a solution of 2.8 g of dicyclohexylamine in 15 ml of ethyl acetate. On seeding and rubbing, the crystalline trans-l-CD-(3-acetylthio)-2-methyl-l- oxopropylJ-4CC(methylamino)carbonyljoxyJ-L-proline dicyclohexylamine salt separates, weight after cooling overnight 5.8 g (colorless); m.p. 187—189° (s. 183°) C26-64° (c, 1% in MeOH). Following recrystallization from 15 ml of methanol —100ml of ether, the colorless solid weighs 4.5 g, m.p. 190—192° CciJp5- 67° (c, 1% in MeOH).
The dicyclohexylamine salt is converted to the free acid by suspending in 50 ml of ethyl acetate cooling, treating with 50 ml of 10% potassium bisulfate and stirring until two clear layers are obtained. After separating the aqueous phase is extracted with ethyl acetate (3X50 ml), the combined organic layers are dried (MgSO^), and the solvent evaporated to give 2.8 g (55%) of trans -1-CD-(3-acetylthio)- 2-methyl-l-oxopropylJ-4CC(methylamino)carbonyljoxyJ-L-proline as a foamy hygroscopic residue.
EXAMPLE 2 trans-1-(D-3-mercapto-2-methyl-l-oxopropyl)-4- 17 49358 EL(methylamino)carbonyloxyJ-L-proline Argon is passed through a cold solution of 6 ml of concentrated ammonium hydroxide in 4 ml of water for 10 minutes. The latter is then added while cooling and under a blanket of argon to the product of Example 1 and the mixture is swirled in an icebath until a pale yellow solution is obtained (about 3 minutes). Stirring under argon is continued at room temperature for a total of 2 hours, then the solution is extracted with 20 ml of ethyl acetate (this and subsequent operations are carried out as much as possible under an argon atmosphere). The aqueous layer is cooled, stirred, layered over with 20 ml of ethyl acetate and acidified portionwise with approximately 13 ml of 1:1 hydrochloric acid. The layers are separated, the aqueous phase is extracted with additional ethyl acetate (3X20ml), the combined ethyl acetate layers are dried (MgSO^), and the solvent evaporated to give trans-1-(D-3- mercapto-2-methyl-l20 oxopropyl)-4-CE(methylamino)carbonyljoxyj -L-proline as a sticky foamy residue. The latter is rubbed under ether and the evaporation repeated, finally at 0.1 —0.2 mm, to yield 2.2 g (90%) of the product as a colorless, somewhat hygroscopic, amorphous solid, m.p. 54—57° (S,45°). CaJ^6 -53° (c, 1% in EtOH). ^8358 The racemic forms of the final products in each of the foregoing examples are produced by utilizing the DL-form of the starting amino acid instead of the L-form.
Similarly, the D-form of the final products in each of the foregoing examples is produced by utilizing the D-form of the starting amino acid instead of the L-form.
EXAMPLE 3 a) N-carbobenzyloxy-cis-4-hydroxy-L-proline, Methyl Ester 6.5 g (0.024 mole) of N-carbobenzyloxy-cis-4hydroxy-L-prolineCJ.A.C.S., 79, 189 (1957)2 is dissolved in 65 ml of methanol, stirred, and treated with 0.65 ml of concentrated sulphuric acid. After stirring at room temperature for one-half hour, the solution is allowed to stand overnight. The bulk of solvent is removed on a rotary evaporator and the oily residue (13 g) is taken up in 70 ml of ether and washed with 35 ml of 10% sodium bicarbonate solution.
The wash is back extracted with 35 ml of ether.
The combined organic layers are dried (MgSO^), and the ether is evaporated to give 6.5 g (96%) of product as a pale yellow viscous oil. 24° (c, 1% in chloroform). b) cis-N-carbobenzyioxy-4-CC(methylamino)carbonyl]oxy] -L-proline, Methyl Ester To a stirred solution of 5.4 g (0.019 mole) of N-carbobenzyloxy-cis-4-hydroxy-L-proline, methyl ester, in 120 ml of acetonitrile is added 5.4 ml of triethylamine, followed by 5.4 ml of methyl isocyanate. After keeping overnight at room temperature and refluxing for two hours, the reaction mixture is worked up as in Example lc to give .6 g (86%) of a pale yellow viscous oil. c) cis-N-carbobenzyloxy-4-CC(methylamino)carbonyl]oxy] -L-proline The crude ester from part b (5.6 g; 0.017 mole) is saponified with 11 ml (0.22 mole) of 2N sodium hydroxide in 45 ml of methanol as in Example Id to give 5.1 g of a foamy residue. The colorless cyclohexylamine salt, prepared in 25 ml of ethanol and 400 ml of ether employing 1.7 g of cyclohexylamine, weighs 4.8 g; m.p. 171—173°. - 16° (c, 1% in ethanol). A sample recrystallized from ethanol-ether shows no change in melting point or optical rotation.
The cyclohexylamine salt yields 3.5 g (65%) of the free acid as a colorless foamy residue. d) cis-4~EE(methylamino)carbonyl]oxy]-L-proline 3.5 (0.011 mole) of cis-N-carbobenzyloxy-425 EC (methylamino)carbonylJoxy]-L-proline is hydrogenated in 130 ml of 2:1 methanol-water employing 1.3 g of 2:1 methanol-water employing 1.3 g of 5% palladium-carbon as in Example le to give 1.9 g (95%) of product as a greyish solid; m.p. 232—234° (dec.), preceded by gradual darkening and sintering.
Ca]25- 42° (c, 0.5% in 1:1 methanol - water). e) cis-l-CD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(methylamino)carbonyljoxyJ-L-proline Interaction of 1.85 g (0.0098 mole) of cis-4CC(methylamino)carbonyljoxyJ-L-proline and 2.0g (0.011 mole) of D-3-acetylthio-2-methylpropanoyl chloride in 30 ml of water in the presence of sodium carbonate as in Example If yields 3.35 g of a gummy product. The dicyclohexylamino salt, prepared in 35 ml of ethyl acetate employing 1.8 g of dicyclohexylamine, weighs 4.0 g; m.p. 177—179°.
Ca]25- 54° (c, 1% in methanol). Following trituration with 20 ml of acetonitrile and cooling, the colorless solid weighs 3.6 g; m.p. 179—181°. CaJ^- 54° (c, 1% in methanol). Treatment with 10% potassium bisulfate and extraction into ethyl acetate yields 2.5 g (76%) of the free acid as a colorless foamy residue.
EXAMPLE 4 cls-1-(D-3-mercapto-2-methyl-l-oxopropyl)-4-CC(methylamino) carbonylJoxyJ-L-proline By treating the material of Example 3 with 5.5 ml of concentrated ammonium hydroxide in 12.5 ml of water according to the procedure described in Example 2, 1.8 g (82%) of the product is obtained as a colorless, hygroscopic, sticky foam Ε“]θ3- 59° (c, 1% in ethanol).
EXAMPLE 5 cis-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl]-4EE(ethylamino)carbonyl]oxy]-L-proline Utilizing the procedure of Example 3 but substituting ethylisocyanate for the methylisocyanate in part b, cis-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl] -4-EE(ethylamino)carbonyl]oxy]-L-proline is obtained.
EXAMPLE 6 cis-1-(D-3-mercapto-2-methyl-l-oxopropyl)-4-EE(ethylamino) carbonyl]oxy]-L-proline By treating the material of Example 5 with ammonia according to the procedure described in Example 4,cis-l(D-3-mercapto-2-methyl-l-oxopropyl)-4-EE(ethylamino) carbonyl]oxy]-L-proline is obtained.
EXAMPLE 7 cis-l-ED-(e-acetylthio)-2-methyl-l-oxopropyl]-4-EE(propylamino) carbonyl]oxy]-L-proline Utilizing the procedure of Example 3 but substituting n-propylisocyanate for the methylisocyanate in part b, cis-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(propylamino)carbonyljoxyJ-L-proline is obtained.
EXAMPLE 8 cis-1-(D-3mercapto-2-methyl-l-oxopropyl)-4EE(propylamino)carbonylJoxyJ-L-proline By treating the material of Example 7 with ammonia according to the procedure described in Example 4, cis-1-(D-3mercapto-2-methyl-l-oxopropyl)—4—EE(propylamino)carbonyljoxyj -L-proline is obtained.
EXAMPLE 9 cis-l-EP-(3-acetylthlo)-2-methyl-l-oxopropylJ-4EE(phenylamino)carbonylJoxyJ-L-proline Utilizing tbe procedure of Example 3 but substituting phenylisocyanate for the methylisocyanate in part b, cis-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(phenylamino)carbonyljoxyJ-L-proline is obtained.
EXAMPLE 10 cis-1-(P-3-mercapto-2-methyl-l-oxopropyl)-4-EE(phenylamino) carbonylJoxyJ-L-proline By treating the material from Example 9 with ammonia according to the procedure described in Example 4, cis-1(D-3-mercapto-2-methyl-l-oxopropyl)-4-EE(phenylamino) carbonylJoxyJ-L-proline is obtained.
EXAMPLE 11 cis-l-ED-(3-acetylthlo)-2-methyl-l-oxopropylJ-423 483S8 ΓΓ(4-chlorophenylamino)carbonyl PoxyD-L-proiine Utilizing the procedure of Example 3 but substituting 4-chlorophenylisocyanate for the methylisocyanate in part b, cis-l-ED-(3-acetylthio)-2methyl-i-oxypropylD-4-LC(4-chlorophenyl) carbonylDoxyD-Lproline is obtained.
EXAMPLE 12 cis-i-(D-3-mercapto-2-methyl-l-oxopropyl)-4-EE(4-chlorophenylamino)carbonylDoxyD-L-proline By treating the material from Example 11 with ammonia according to the procedure described in Example 4, cis-1(D-3-mercapto-2-methyl-l-oxopropyl)-4-EC(4-chlorophenyl) carbonylDoxyD-L-proline is obtained.
EXAMPLE 13 cis-l-C D-(3-acetyithio)-2-methyl-l-oxopropylD-4CE (3-trifluoromethylphenylamino)carbonylDoxyD-L-proline Utilizing the procedure of Example 3 but substituting 3-trifluoromethylphenylisocyanate in place of the methylisocyanate in part b, cis-l-ED-(3-acetylthio) -2-methyl-l-oxopropylD-4- EE(3-trifluoromethylphenyl) carbonylD oxyD -L-proline is obtained.
EXAMPLE 14 cis-l-EP-(acetyithio)-2-methyl-l-oxopropylP-4EE(2-methoxyphenylamino)carbonylDoxyD-L-proline Utilizing the procedure of Example 3 but substituting ,. 49358 2-methoxyphenylisocyanate for methylisocyanate in part b, cis-l-CD-(acetylthio)-2-methyl-l-oxopropylJ-4CC(2-methoxyphenyl)carbonyljoxyJ-L-proline is obtained. EXAMPLE 15 trans-l-CD-(benzoylthio)-2-methyl-l-oxopropylJ-4CC (2-ethylphenylamino)carbonyljoxyJ-L-proline Utilizing the procedure of Example 1 but substituting 2-ethylphenylisocyanate for the methylisocyanate in part c and D-3-benzoylthio~2-methylpropanoyl chloride for the D-3-acethythio-2- methylpropanoyl chloride in part f, trans-l-CD-(benzoylthio)-2-methyl-l-oxopropylJ-4CC(2-ethylphenyl)carbonylJoxyjL-proline is obtained.
EXAMPLE 16 trans-l-CD-(phenacetylthio)-2-methyl-l-oxopropylJ-415 CC(4-methylthlophenylamlno)carbonylJoxyJ-L-proline Utilizing the procedure of Example 1 but substituting 4-methylthiophenylisocyanate for the methylisocyanate in part c, and D-phenylacetylthio-2-methylpropanoyl chloride for the D-(3-acetylthio)-2-methylpropanoyl chloride in part f, trans-l-CD-(phenacetylthio)-2-methyl-l-oxopropylJ-4CC (4-methylthiophenyl)carbonyfloxyJ-L-proline is obtained. EXAMPLE 17 trans-l-CD-(3-phenylpropionylthio)-2-methyl-l-oxopropylJ-4CC(3-bromophenylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 1 but substituting 3-bromophenylisocyanate for the methylisocyanate in part c, and D-(3-phenylpropionylthio)-2-methylpropanoyl chloride for the D-(3-acetylthio)-2-methylpropanoyl chloride in part f, trans-l-ED-(3-phenylpropionylthio)-2-methyl-l5 oxopropylJ-4-EE(3-bromophenyl)carbonylJoxyJ-L-proline is obtained.
EXAMPLE 18 trans-l-EP-3-acetylthio)-2-methyl-l-oxopropylJ-4EE(cyclopentylamino)carbonylJoxyJ-L-proline 10 Utilizing the procedure of Example 1 but substituting cyclopentylisocyanate for the methylisocyanate in part c, trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(cyclopentylamino)carbonylJoxyJ-L-proline is obtained. EXAMPLE 19 trans-l-ED- (3-acetylthio) ^-methyl-l-oxopropylj^EE(cyciohexylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 1 but substituting cyclohexylisocyanate for the methylisocyanate in part c, trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-420 EE(cyciohexylamino)carbonylJoxyJ-L-proline is obtained EXAMPLE 20 cis-l-EP-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(allylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 3 but substituting 25 allylisocyanate for the methylisocyanate in part b, cis-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(allylamino)carbonylJoxyJ-L-proline is obtained 4-9358 EXAMPLE 21 cis-l-(D-B-mercapto^-methyl-l-oxopropyl) -4EE(allylamino)carbonyl ]oxyZ]-L-proline By treating the material from Example 20 with ammonia according to the procedure described in Example 4, cis-1(D-3-mercapto-2-methyl-l-oxopropyl)-4-EC(allylamino) carbonyl]oxyZ]-L-proline is obtained EXAMPLE 22 trans-l-EP-(3-Acetyithio)-2-methyl-l-oxopropyl -4EE(dimethylamino)carbonyldoxy-L-proline a) trans-N-Carbobenzyloxy-4-EE(dimethylamino)carbonyljoxy]L-proline, methyl ester A solution of N-carbobenzyloxy-trans-4-hydroxy-Lproline methyl ester (Example 1, part b) in chloroform is treated dropwise with an equivalent quantity of dimethylcarbamyl chloride. The mixture is stirred for two hours, washed with water and the organic phase is dried over MgSO^. The solution is filtered and solvent evaporated to give trans-N-carbobenzyloxy-4EE (dimethylamino) carbonyl]oxy>L- proline, methyl ester. b) trans-N-carbobenzyloxy-4-EE(dimethylamino)carhonylloxy] -L-prollne Hydrolysis of the methyl ester from part a with sodium hydroxide solution in the manner described in Example 1, part d, gives trans-N-carbobenzyloxy-427 (dimethylamino)carbonylJoxyJ-L-proline. c) trans-4-CC(dimethylamino)carbonylloxy]-L-proline Hydrogenation of the material from part b according to the procedure described in Example 1, part e, gives trans-4-EE(dimethylamino)carbonylJoxyJ-L- proline. d) trans-i-CD-(3-acetylthio)-2-methyl-l-oxopropyl]-4EC (dimethylamino) carbonyl]oxyZ]-L-proline Treatment of the material from part c with an equivalent quantity of D-3-acetylthio-2-methylpropanoyl chloride according to the procedure described in Example 1, part f, gives trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl2-4EE(dimethyl-amino)carbonylJoxyJ-L-proline.
EXAMPLE 23 trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl]-4EE(pyrrolidino)carbonyl]oxyJ-L-proline Utilizing the procedure described in the preparation of Example 22 but substituting pyrrolidinocarbamyl chloride for the dimethylaminocarbamyl chloride in part a, trans-lED- (3-acetylthio)-2-methyl-l-oxopropyl[]-4-CC(pyrrolidino) carbonylJoxyJ-L-proline is obtained.
EXAMPLE 24 trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl]-4ΓΓ(piperidino)carbonyl2oxyJ-L-proline Utilizing the procedure described in the preparation of Example 22, but substituting piperidinocarbamyl chloride for the dimethylaminocarbamyl chloride in part a, trans-1LD-(3-acetylthio)-2-methyl-l-oxopropyl]-4-CE(piperidino) carbonyl]oxy]-L-proline is obtained.
EXAMPLE 25 trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropyl]-4EE(morpholino)carbonyl]oxy]-L-proline Utilizing the procedure used in the preparation of Example 22 but substituting morpholinocarbamyl chloride for the dimethylaminocarbamyl chloride in part a, trans -1-Ed-(3-acetylthio)-2-methyl-l-oxopropyl]-4EE(morpholino)carbonyl]oxy]-L-proline is obtained.
EXAMPLE 26 trans-1-(2-acetylthio-l-oxoethyl)-4-EE(methylamino) carbonyl]oxy]-L-prollne Utilizing the procedure described in the preparation of Example 1 but substituting 2-acetylthioacetyl chloride for the D-(3-acetylthio)-2-methylpropanoyl chloride in part f, trans-1-(2-acetylthio-l-oxoethyl)-4-EE(methylamino)carbonyl] oxy]-L-proline is obtained.
EXAMPLE 27 trans-1-(4-acetylthio-l-oxobutyl)-4-EE(methylamino) carbonyljoxyj-D-prollne Utilizing the procedure described in the preparation . of Example 1 but substituting trans-4-hydroxy-D-proline for the trans-4-hydroxy-L-proline in part a, and 4-acetylthiobutyroyl 9 3 58 chloride for the D-(3-acetylthlo)-2-methylpropanoyl chloride in part f, trans-1-(4-acetylthio-l-oxobutyl)-4EE(methylamino)carbonyljoxyJ-D-proline is obtained.
EXAMPLE 28 cis-1-(4-acetylthio-4-methyl·-l·-oxobutyl)-3EE(methylamino)carbonyljoxyj -L-proline Utilizing the procedure described in the preparation of Example 3 but substituting 4-acetylthiovaleroyl chloride for the D-3-(acetylthio)-3-methylpropionyl chloride in part e, cis-1-(4-acetylthio-4-methyl-l-oxobutyl)-3-EE(methylamino) carbonylJoxyJ-L-proline is obtained.
EXAMPLE 29 trans-l-LL-(3-acetylthio)-2-ethyl-l-oxopropylJ-3EE(methylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 1 but substituting trans-3-hydroxy-L-proline for trans-4- hydroxy-L-proline in part a and L-(3-acetylthio)-2-ethylpropionyl chloride for the D-3-(acetylthio)-3- methylpropionyl chloride in part f trans-l-EL-(3-acetylthio)-2-ethyl-l-oxopropylJ-3EE(methylamino)carbonylJoxyJ-L-proline is obtained.
EXAMPLE 30 trans-l-ED-(3-acetylthio)-2-methyl-l-oxopropylJ-4EE(aminocarbonyl·)oxoJ-L-proline, Methyl Ester A solution of equivalent quantities of N-carbobenzyloxy -trans-4-hydroxy-L-proline, methyl ester from Example 1, part b, and dimethylaniline is treated with a solution of phosgene in toluene. After standing overnight an equivalent quantity of ammonia is passed through the solution of trans-N- carbobenzyloxy-4-E(chlorocarbonyl) oxy1-L-proline, methyl ester. After standing for twelve hours at room temperature, the solution is washed with water, dried over magnesium sulfate, filtered and the solvent evaporated to give trans-N-carbobenzyloxy -4-E(aminocarbonyl)oxyJ-L-proline, methyl ester. b) trans-N-carbobenzyloxy-4-E(aminocarbonyl)oxyJ-L-proline Hydrolysis of the methyl ester from part a with sodium hydroxide solution in the manner described in Example 1, part d, gives trans-N-carbobenzyloxy-4E(aminocarbonyl)oxyZ-L-proline c) trans-4-C(aminocarbonyl)oxyJ-L-proline Hydrogenation of the material from part b according to the procedure described in Example 1, part e, gives trans-4-E(aminocarbonyl)oxyJ-L-proline. d) trans-l-E(d-(3-acetyithio)-2-methyl-l-oxopropylJ-4E(aminocarbonyl)oxyJ-L-proline Treatment of the material from part c with an equivalent quantity of D-3-acetylthio-2-methyl-propanoyl chloride according to the procedure described in Example 1, part f, gives trans-l-Lb-(3-acetylthio)-2-methyl-l-oxopropylJ-4E(aminocarbonyl)oxyJ-L-proline.
EXAMPLE 31 trans-1-ΓΡ-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(diisopropylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 30, but substituting diisopropylamine for the ammonia in part a, trans-l-CD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(cyclopropylamino)carbonylJoxyJ-L-proline is obtained. EXAMPLE 32 trans-i-CD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(cyclopropylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 30, but substituting cyclopropylamine for the ammonia in part a, trans-l-CD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(cyclopropylamino)carbonylJoxyJ-L-proline is obtained. EXAMPLE 33 trans-l-CD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(n-butylamino)carbonylJoxyJ-L-proline Utilizing the procedure of Example 30, but substituting n-butylamine for the ammonia in part a, trans-l-CD-(3-acetylthio)-2-methyl-l-oxopropylJ -4-CC(n-butylamino)carbonylJoxyJ-L-proline is obtained.
EXAMPLE 34 trans-l-LD-(3-acetylthio)-2-methyl-l-oxopropylJ-4CC(propargylamino)carbonyljoxyJ-L-prollne Utilizing the procedure of Example 30, but substituting propargylamine for the ammonia in part a, trans-1Cd-(3-acetylthio)-2-methyl-l-oxopropyl3-4CC(propargylamino)carbonylloxyZl-L-proline is obtained. EXAMPLE 35 trans-l-Cp-(3-acetylthio)-2-methyi-l-oxopropyl2-4LC(methylamino)carbonylloxy]-L-proline, Methyl Ester A solution of the material from Example 1 in ether is treated with a slight excess of diazomethane. After stirring at room temperature for two hours, the solvent is evaporated to give trans-1-Cd-(3-acetylthio)-2-methyll-oxopropyl2-4-CC(methylamino)carbonyljoxy2-L-proline, methyl ester.
EXAMPLE 36 S,S-dimer of trans-1-(D-3-mercapto-2-methyl-l-oxopropyl)-4CC(methylamino)carbonylloxyJ-L- proline A solution of the material from Example 2 is dissolved in ethanol, stirred and treated with a solution of one equivalent of iodine in ethanol, the pH of the solution is maintained at 6—7 by the addition of N sodium hydroxide solution. The solvent is evaporated and the residue is extracted with ethyl acetate. After drying over MgSO^, the solution is filtered and the solvent is removed to give S,S-dimer of trans 1-1(D-3-mercapto-2methyl-l-oxopropyl)-4-CC(methylamino)carbonylloxyJ-L-proline.
EXAMPLE 37 S,S,-dimer of cis-1-(D-3-mercapto-2-methyl-l-oxopropyl·) -4-CC(methylamino)carbonylDoxoP-L-proline Oxidation of the material from Example 4 with a solution of iodine according to the procedure used in Example 36 gives S,S-dimer of cis-1-(D-3-mercapto-2-methyl-l-oxopropyl) —4—LC(methylamino) carbonylJoxoρ-L-proline.
EXAMPLE 38 Sodium Salt of trans-1- D-(3-acetylthio)-2-methyl-l-oxopropyl -4-CC(methylamino)carbonylPoxyP-L-proline A solution of 2.9 g of material from Example 1 in ml of water is treated with 0.84 g of sodium bicarbonate.
The solution is freeze-dried to give the sodium salt of trans-l-CD-(3-acetylthio)-2-methyl-l-oxopropyip-415 CC(methylamino)carbonyiPoxyp-L-proline.

Claims (3)

1. CLAIMS:1. A compound of the formula oco-N HN-1— COOH wherein each of R q and Ry, which are similar or dissimilar, is hydrogen, lower alkyl, lower cycloalkyl, allyl, propargyl, phenyl or substituted phenyl, or R Q and Ry can, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered heterocyclic ring.
2. A compound as claimed in Claim 1 wherein R Q is lower alkyl.
3. A compound as claimed in Claim 1 wherein R Q is methyl and Ry is hydrogen.
IE498580A 1979-01-15 1980-01-10 Carbamate derivatives of hydroxy prolines IE49358B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US317879A 1979-01-15 1979-01-15
IE488580 1980-01-10

Publications (1)

Publication Number Publication Date
IE49358B1 true IE49358B1 (en) 1985-09-18

Family

ID=26319382

Family Applications (1)

Application Number Title Priority Date Filing Date
IE498580A IE49358B1 (en) 1979-01-15 1980-01-10 Carbamate derivatives of hydroxy prolines

Country Status (1)

Country Link
IE (1) IE49358B1 (en)

Similar Documents

Publication Publication Date Title
US4217359A (en) Carbamate derivatives of mercaptoacyl hydroxy prolines
US4721723A (en) Anti-depressant crystalline paroxetine hydrochloride hemihydrate
EP0997147B1 (en) Amino acid derivatives
SE447477B (en) BRAND CAPACULTURE DERIVATIVES OF A SUBSTITUTED PROLINE, PROCEDURE FOR PREPARING THIS AND A PHARMACEUTICAL ACTIVE COMPOSITION CONTAINING THE ASSOCIATION
CH624932A5 (en)
EP1472214A2 (en) Compounds for inhibiting insulin secretion and methods related thereto
IE51409B1 (en) Amide derivatives
IE912529A1 (en) Acetamide derivatives
DE60316683T2 (en) PHENYLCYCLOHEXYLPROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATIONS
NZ229630A (en) Mercaptophenylalkylamide derivatives and pharmaceutical compositions thereof
US3988464A (en) Cyclopropylamines as pharmaceuticals
US4797496A (en) Process for the preparation of pyrrolidone derivatives
US4483861A (en) Antihypertensive sulfur-containing compounds
US4965283A (en) Amino acid esters, process for the preparation thereof and use thereof
US4252943A (en) Carbamate derivatives of mercaptoacyl hydroxy prolines
EP0053017B1 (en) Amide derivatives
IE49358B1 (en) Carbamate derivatives of hydroxy prolines
US4181663A (en) Selenium containing derivatives of proline and pipecolic acid
GB2088875A (en) Carbamate Derivatives of Hydroxy Prolines
US4102890A (en) 2-Amino oxazolines and process for making the same
EP0017411B1 (en) Phthalazine cardiac stimulants, processes for preparing them, and pharmaceutical compositions containing them
US5166361A (en) Methods for preparing captopril and its analogues
JPH05345765A (en) Dibenzazepine derivative
US20080108828A1 (en) Optically Active 4,4-Di-Substituted Oxazolidine Derivative and Method for Producing Same
US4594344A (en) 1-aryloxypropanolamines